Currently out of the existing stock ratings of Emma Nealon, 6 are a BUY (100%).

Emma Nealon

Work Performance Price Targets & Ratings Chart

Analyst Emma Nealon works with a stock forecast success ratio of 13.33% fulfilled within 52.4 days on average.

Emma Nealon’s has documented 23 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on EQ, Equillium at 14-Aug-2023.

Wall Street Analyst Emma Nealon

Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 8/14/2023. The price target of $2.8 was fulfilled within 190 days with a profit of $2.01 (254.43%) receiving and performance score of 13.39.

Average potential price target upside

FMTX Forma Therapeutics Holdings ORTX Orchard Therapeutics PLC EQ Equillium KDNY Chinook Therapeutics ALLK Allakos

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

49

1 years 6 months 27 days ago

0/3 (0%)

$39.17 (398.47%)

Hold

20

$-0.01 (-0.05%)

40

1 years 6 months 27 days ago

1/2 (50%)

$0.02 (0.10%)

41

Hold

20

$-0.01 (-0.05%)

64

1 years 6 months 27 days ago

1/2 (50%)

$0.02 (0.10%)

41

Hold

20

$-0.01 (-0.05%)

53

1 years 6 months 27 days ago

1/4 (25%)

$0.02 (0.10%)

41

Buy

23

$2.99 (14.94%)

40

1 years 10 months 2 days ago

0/4 (0%)

$17.23 (298.61%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Emma Nealon?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?